Search

Displaying results 2541 - 2550 of 5925 in total
  1. Drug

    Hydroxindasol

    go.drugbank.com/drugs/DB20308
    Experimental

    Hydroxindasol has a monoisotopic molecular weight of 310.17 Da.

  2. Drug

    Isaxonine

    go.drugbank.com/drugs/DB20311
    Experimental

    Isaxonine has a monoisotopic molecular weight of 137.1 Da.

  3. Drug

    Imanixil

    go.drugbank.com/drugs/DB20315
    Experimental

    Imanixil has a monoisotopic molecular weight of 394.14 Da.

  4. Drug

    Trocimine

    go.drugbank.com/drugs/DB20325
    Experimental

    Trocimine has a monoisotopic molecular weight of 307.18 Da.

  5. Drug

    Milpecitinib

    go.drugbank.com/drugs/DB21676
    Experimental

    Milpecitinib has a monoisotopic molecular weight of 380.13 Da.

  6. Drug

    Claziprotamide

    go.drugbank.com/drugs/DB21687
    Experimental

    Claziprotamide has a monoisotopic molecular weight of 374.13 Da.

  7. Drug

    Aloe vera leaf

    go.drugbank.com/drugs/DB13906
    ApprovedInvestigational

    Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern peninsula and various islands. Aloe vera, or Aloe barbadensis miller, is the most common species of Aloe that is cultivated for agr...

    Synonyms: Lu hui ye, Lu hui (aloe vera)
  8. Drug

    Tapinarof

    go.drugbank.com/drugs/DB06083
    ApprovedInvestigational

    Tapinarof is a novel, first-in-class, small-molecule AhR agonist that is indicated for the treatment of adult psoriasis. It is available as a topical cream to be applied to the affected area once daily. Tapiranof was first discovered as ...

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  9. Drug

    Benserazide

    go.drugbank.com/drugs/DB12783
    ApprovedInvestigational

    When levodopa is used by itself as a therapy for treating Parkinson's disease, its ubiquitous metabolism into dopamine is responsible for a resultant increase in the levels of circulating dopamine in the blood and to various extracerebra...

    Mixtures: LEVODOPA P BENS AL 100/25, LEVODOPA P BENS AL 100/25
  10. Drug

    Vestronidase alfa

    go.drugbank.com/drugs/DB12366
    ApprovedInvestigational

    MPS VII is a progressive condition that affects most tissues and organs due to the lack of a lysosomal enzyme called beta-glucuronidase, leading to buildup of toxic metabolites. … Some affected individuals do not survive infancy, while others may live into adolescence or adulthood and patients may experience developmental delay and progressive intellectual disability [FDA Label]